Skip to main content

Table 1 Baseline sociodemographic and clinical characteristics

From: Effects of omega-3 fatty acids on arterial stiffness in patients with hypertension: a randomized pilot study

  

Placebo (N = 35)

N (%) or Mean (SD)

Omega-3 (N = 27)

N (%) or Mean (SD)

Overall (N = 62)

N (%) or Mean (SD)

Age (years)

 

60.2 (10.8)

62.3 (9.7)

61.1 (10.3)

Female Gender

 

22 (63 %)

18 (67 %)

40 (65 %)

Race/ethnicity

Non-Latino White

7 (20 %)

11 (41 %)

18 (29 %)

 

Latino

28 (80 %)

16 (59 %)

44 (71 %)

Educational Status

Did Not Complete High School

18 (51 %)

10 (37 %)

28 (45 %)

 

Completed High School

9 (26 %)

10 (37 %)

19 (31 %)

 

Completed College

8 (23 %)

7 (26 %)

15 (24 %)

Unemployed

 

28 (80 %)

21 (81 %)

49 (80 %)

Body Mass Index (kg/m2)

 

31.5 (7.1)

33.9 (8.6)

32.6 (7.8)

Systolic Blood Pressure (mm Hg)a

 

137 (16)

128 (14)

133 (16)

Diastolic Blood Pressure (mm Hg)

 

82 (9)

78 (10)

81 (10)

Antihypertensive Medication

 

32 (91 %)

21 (78 %)

53 (85 %)

Statin therapy

 

17 (49 %)

11 (41 %)

28 (45 %)

Total cholesterol (mg/dL)

 

179 (43)

179 (38)

179 (40)

Triglycerides (mg/dL)

 

188 (103)

173 (65)

182 (89)

HDL-C (mg/dL)

 

48.4 (14.9)

44.9 (12.4)

46.9 (13.9)

LDL-C (mg/dL)

 

97 (38)

99 (29)

98 (34)

Diabetes diagnosis

 

19 (54 %)

12 (48 %)

31 (52 %)

Hemoglobin A1c (%)

 

6.7 (1.8)

6.3 (1.3)

6.6 (1.6)

Glucose (mg/dL)

 

127 (61)

111 (25)

120 (49)

Smoking status

Current

12 (34 %)

6 (22 %)

18 (29 %)

 

Former

23 (66 %)

21 (78 %)

44 (71 %)

hsCRP (mg/L)

 

3.42 (3.35)

5.63 (5.05)

4.38 (4.29)

Adiponectin (ug/mL)

 

10.6 (8.3)

12.2 (7.8)

11.4 (8.1)

LpPLA2 mass (ng/mL)

 

244 (46)

252 (62)

247 (53)

Mean PWV (cm/s)

 

1690 (335)

1602 (324)

1652 (330)

  1. PWV pulse wave velocity, CRP C-reactive protein, Lp-PLA2 lipoprotein-associated phospholipase A2
  2. aSystolic Blood Pressure difference between groups at p < 0.05 using Wilcoxon rank sum test